WAY-270250 is primarily used in scientific research to investigate the role of serotonin receptors, particularly the 5-HT6 receptor subtype, in cognitive and neurological functions. It acts as a selective antagonist at these receptors, making it a valuable tool for studying conditions such as Alzheimer's disease, schizophrenia, and other disorders involving cognitive impairment. Researchers use WAY-270250 to explore how modulation of the 5-HT6 pathway affects memory, learning, and behavior in preclinical models. Its application is confined to laboratory and experimental settings, aiding in the development of potential therapeutics targeting central nervous system disorders.